$803.17
+
$19.99 (2.55%)
End-of-day quote: 05/21/2024
NYSE:LLY
Eli Lilly and Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr927.20 | kr696.07 | 0.00% | 14 | kr4.11T |
| MRK | Merck | NYSE | Outperform | $130.76 | $130.51 | 0.00% | 11 | $331.19B |
| AZN | AstraZeneca PLC | LSE | Outperform | £123.64 | £165.99 | 0.00% | 16 | £191.67B |
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $590.12 | $591.94 | 0.00% | 1 | $225.26B |
| ROG | Roche Holding | SWX | Hold | CHF234.40 | CHF307.83 | 0.00% | 9 | CHF189.48B |
| NOVN | Novartis | SWX | Hold | CHF93.89 | CHF105.00 | 0.00% | 9 | CHF191.57B |
| ABT | Abbott Laboratories | NYSE | Outperform | $102.96 | $118.92 | 0.00% | 7 | $179.11B |
| AMGN | Amgen | NasdaqGS | Outperform | $314.85 | $303.65 | 0.00% | 8 | $168.90B |
| PFE | Pfizer | NYSE | Outperform | $28.56 | $32.87 | 0.00% | 6 | $161.84B |
| SAN | Sanofi | ENXTPA | Outperform | 90.00€ | 102.80€ | 0.00% | 9 | 112.51€B |
| GSK | GSK | LSE | Outperform | £17.56 | £17.30 | 0.00% | 12 | £71.61B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $42.27 | $58.15 | 0.00% | 10 | $85.69B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.29 | $87.82 | 0.00% | 14 | $83.83B |
| ZTS | Zoetis | NYSE | Outperform | $172.79 | $220.47 | 0.00% | 5 | $78.84B |
| MRNA | Moderna | NasdaqGS | Outperform | $143.69 | $135.42 | 0.00% | 1 | $55.07B |
| 4519 | Chugai Pharmaceutical | TSE | Outperform | ¥5.04k | ¥4.92k | 0.00% | 0 | ¥8.29T |
| SUNPHARMA | Sun Pharmaceutical Industries | NSEI | Outperform | Rp1.54k | Rp1.52k | 0.00% | 25 | Rp3.70T |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| BAYN | Bayer | XTRA | Hold | 28.32€ | 45.15€ | 0.00% | 4 | 27.82€B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.59 | $11.59 | 0.00% | 9 | $18.79B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $149.62 | $245.24 | 0.00% | 7 | $18.93B |
| BGNE | BeiGene | NasdaqGS | Buy | $167.39 | $285.19 | 0.00% | 2 | $17.51B |
| DGX | Quest Diagnostics | NYSE | Outperform | $143.34 | $141.17 | 0.00% | 8 | $15.92B |
| 4507 | Shionogi & | TSE | Outperform | ¥7.04k | ¥7.12k | 0.00% | 0 | ¥2.16T |
| BIM | bioMérieux | ENXTPA | Outperform | 94.30€ | 105.55€ | 0.00% | 1 | 11.73€B |
| 4523 | Eisai | TSE | Outperform | ¥6.64k | ¥9.58k | 0.00% | 0 | ¥1.97T |
| FME | Fresenius Medical Care AG & Co... | XTRA | Hold | 39.60€ | 41.13€ | 0.00% | 12 | 11.38€B |
| IPN | Ipsen | ENXTPA | Outperform | 121.30€ | 127.95€ | 0.00% | 0 | 9.88€B |
| 4528 | Ono Pharmaceutical | TSE | Hold | ¥2.29k | ¥2.76k | 0.00% | 0 | ¥1.09T |
| ITCI | Intra-Cellular Therapies | NasdaqGS | Outperform | $67.00 | $79.10 | 0.00% | 10 | $6.86B |
| BPMC | Blueprint Medicines | NasdaqGS | Outperform | $103.63 | $85.71 | 0.00% | 5 | $6.78B |
| EXEL | Exelixis | NasdaqGS | Outperform | $21.02 | $26.44 | 0.00% | 5 | $6.34B |
| ZEAL | Zealand Pharma A/S | CPSE | Buy | kr622.50 | kr357.00 | 0.00% | 2 | kr38.52B |
| HALO | Halozyme Therapeutics | NasdaqGS | Outperform | $45.54 | $47.50 | 0.00% | 3 | $5.58B |
| HLUN A | H. Lundbeck A/S | CPSE | Outperform | kr37.72 | kr190.00 | 0.00% | 6 | kr36.60B |
| ALKS | Alkermes | NasdaqGS | Outperform | $24.34 | $33.27 | 0.00% | 3 | $4.11B |
| NNI | Nelnet | NYSE | Hold | $108.03 | $95.00 | 0.00% | 1 | $3.63B |
| VIRP | Virbac | ENXTPA | Outperform | 359.00€ | 348.34€ | 0.00% | 5 | 2.98€B |
| 300529 | Jafron Biomedical | SZSE | Buy | ¥28.97 | ¥26.62 | 0.00% | 0 | ¥22.72B |
| BHC | Bausch Health Companies | NYSE | Hold | $6.55 | $9.50 | 0.00% | 5 | $2.55B |
| 4506 | Sumitomo Pharma | TSE | Underperform | ¥464.00 | ¥0.00 | 0.00% | 0 | ¥396.90B |
| INDV | Indivior PLC | LSE | Buy | £13.28 | £28.89 | 0.00% | 4 | £1.95B |
| PFIZER | Pfizer | NSEI | Outperform | Rp4.38k | Rp4.53k | 0.00% | 3 | Rp204.63B |
| AMPH | Amphastar Pharmaceuticals | NasdaqGS | Outperform | $41.91 | $69.00 | 0.00% | 0 | $2.09B |
| VETO | Vetoquinol | ENXTPA | Hold | 102.00€ | 106.50€ | 0.00% | 0 | 1.12€B |
| OPK | OPKO Health | NasdaqGS | Outperform | $1.01 | $6.70 | 0.00% | 0 | $1.18B |
| HIMX | Himax Technologies | NasdaqGS | Outperform | $6.54 | $7.00 | 0.00% | 1 | $995.93M |
| 524735 | Hikal | BSE | Buy | Rp293.55 | Rp328.00 | 0.00% | 1 | Rp36.36B |
| AMRN | Amarin | NasdaqGM | Hold | $0.90 | $2.05 | 0.00% | 1 | $378.19M |
| VNDA | Vanda Pharmaceuticals | NasdaqGM | Outperform | $5.11 | $4.25 | 0.00% | 0 | $311.94M |
| XERS | Xeris Biopharma Holdings | NasdaqGS | Buy | $2.00 | $4.60 | 0.00% | 1 | $260.93M |
| CHRS | Coherus BioSciences | NasdaqGM | Outperform | $2.08 | $10.86 | 0.00% | 3 | $255.37M |
| OOMA | Ooma | NYSE | Buy | $7.52 | $18.60 | 0.00% | 4 | $255.16M |
| PBYI | Puma Biotechnology | NasdaqGS | Hold | $4.17 | $4.67 | 0.00% | 2 | $232.99M |
| EDT | Spectral Medical | TSX | Buy | C$0.50 | C$1.60 | 0.00% | 0 | C$167.15M |
| BIOC | GlaxoSmithKline S.A.E | CASE | - | £29.01 | £0.00 | 0.00% | 0 | £3.30B |
| CODA | Coda Octopus Group | NasdaqCM | Buy | $5.69 | $8.00 | 0.00% | 0 | $66.93M |
| CTSO | Cytosorbents | NasdaqCM | Outperform | $0.94 | $4.50 | 0.00% | 1 | $47.35M |
| MTNB | Matinas BioPharma Holdings | NYSEAM | Buy | $0.17 | $0.65 | 0.00% | 0 | $44.04M |
| ECOR | electroCore | NasdaqCM | Buy | $6.82 | $22.75 | 0.00% | 1 | $41.12M |
| PMN | ProMIS Neurosciences | NasdaqCM | Buy | $1.83 | $18.49 | 0.00% | 0 | $34.98M |
| POXEL | Poxel | ENXTPA | - | 0.62€ | 3.50€ | 0.00% | 0 | 25.85€M |
| ACST | Acasti Pharma | NasdaqCM | Buy | $2.73 | $16.34 | 0.00% | 0 | $26.98M |
| ORGS | Orgenesis | NasdaqCM | - | $0.28 | $9.00 | 0.00% | 0 | $16.26M |
| LXXG.Q | LexaGene Holdings | OTCPK | - | $0.11 | $0.75 | 0.00% | 0 | $11.34M |
| 542934 | Chandra Bhagat Pharma | BSE | - | Rp117.80 | Rp0.00 | 0.00% | 0 | Rp866.55M |
| ULGX | Urologix | OTCPK | - | $0.00 | $1.50 | 0.00% | 0 | $0.00M |
| CDXI | Cardax | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
